Allergan gets FDA nod for new antipsychotic

September 17, 2015 7:38 PM

21 0

Allergan Plc said on Thursday the U.S. Food and Drug Administration approved its new antipsychotic drug to treat bipolar disorder and schizophrenia.

The drug, Vraylar, carries a boxed warning on increased risk of death associated with its use in older people with dementia-related psychosis, the FDA said on its website.

Also read: FDA proposes drug development guidance for rare pediatric diseases

Read more

To category page

Loading...